Shares of Summit Therapeutics SMMT tanked nearly 31% on Friday after it reported mixed results from the phase III HARMONi ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its ...

Summit Therapeutics' recent stock sell-off reflects regulatory uncertainty rather than drug failure. Click here to read an ...

Dr. Bryant Lin, who has stage 4 lung cancer, created a Stanford class that follows his journey, offering students an ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results ...